Oculis Holding AG Ordinary shares

OCSNASDAQUSD
27.10 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 04:14 PM EDT)
🟢Market: OPEN
Open?$26.40
High?$27.50
Low?$26.42
Prev. Close?$27.12
Volume?605.9K
Avg. Volume?N/A
VWAP?$26.94
Bid / Ask
Bid?$22.89 × 100
Ask?$31.15 × 100
Spread?$8.26
Midpoint?$27.02
Valuation & Ratios
Market Cap?1.5B
Shares Out?58.0M
Float?34.8M
Float %?66.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
xxx
Related Companies
Loading...
News
Profile
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Employees
60
Market Cap
1.5B
Industry
N/A
Listed
2023-03-03